Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Trial of Radiation Therapy and Sorafenib for Treatment of Unresectable Liver Metastases

NCT00892424 is registered in ClinicalTrials.gov with University Health Network, Toronto as lead sponsor.

NCT NCT00892424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00892424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Trial of Radiation Therapy and Sorafenib for Treatment of Unresectable Liver Metastases
Lead sponsor
University Health Network, Toronto
Phase
Phase 1/2
Overall status
Completed
Start date
November 30, 2008
Completion date
September 8, 2020
Enrollment
54 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, liver metastasis